Neither metformin, ivermectin, nor fluvoxamine had any impact on reducing disease severity, hospitalization, or death from COVID-19, according to results from more than 1,000 overweight or obese adult patients in the COVID-OUT randomized trial. However, metformin showed some potential in a secondary analysis. Early treatment to prevent severe disease remains a goal in managing […]